Coloring Brain Tumor with Multi-potent Micellar Nanoscale Drug Delivery System

被引:0
作者
Chong, Kyuha [1 ]
Choi, Kyungsun
Kim, EunSoo
Han, Eun Chun [1 ]
Lee, Jungsul
Cha, Jungwha
Ku, Taeyun [1 ]
Yoon, Jonghee
Park, Ji-Ho
Choi, Chulhee [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea
来源
NANOSYSTEMS IN ENGINEERING AND MEDICINE | 2012年 / 8548卷
关键词
Brain tumor; glioblastoma multiforme; photodynamic therapy; photodynamic diagnosis; drug delivery system; nanoparticle; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; MALIGNANT GLIOMA; RESECTION;
D O I
10.1117/12.946103
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Brain tumor, especially glioblastoma multiforme (GBM), is one of the most malignant tumors, which not only demands perplexing treatment approaches but also requires potent and effective treatment modality to deal with recurrence of the tumor. Photodynamic therapy (PDT) is a treatment which has been recommended as a third-level treatment. We are trying to investigate possibility of the PDT as an efficient adjuvant therapeutic modality for the treatment of brain tumor. Inhibition of tumor progression with photosensitizer was verified, in vitro. With micellar nanoscale drug delivery system, localization of the tumor was identified, in vivo, which is able to be referred as photodynamic diagnosis. With consequent results, we are suggesting photodynamic diagnosis and therapy is able to be performed simultaneously with our nanoscale drug delivery system.
引用
收藏
页数:6
相关论文
共 14 条
[1]   Improving resection of malignant glioma [J].
Barker, Fred G. ;
Chang, Susan M. .
LANCET ONCOLOGY, 2006, 7 (05) :359-360
[2]   Hematoporphyrin derivative-mediated photodynamic therapy inhibits tumor growth in human cholangiocarcinoma in vitro and in vivo [J].
Cao, Liang-qi ;
Xue, Ping ;
Lu, Hai-wu ;
Zheng, Qiang ;
Wen, Zi-long ;
Shao, Zhi-jian .
HEPATOLOGY RESEARCH, 2009, 39 (12) :1190-1197
[3]  
Chong K., 2011, CURRENT OPTICAL IMAG, P155
[4]   Nanoparticles for drug delivery: The need for precision in reporting particle size parameters [J].
Gaumet, Marie ;
Vargas, Angelica ;
Gurny, Robert ;
Delie, Florence .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (01) :1-9
[5]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[6]   Epidemiology of primary brain tumor [J].
Loiseau, H. ;
Huchet, A. ;
Rue, M. ;
Cowppli-Bony, A. ;
Baldi, I. .
REVUE NEUROLOGIQUE, 2009, 165 (8-9) :650-670
[7]   Photodynamic therapy for prostate cancer-a review of current status and future promise [J].
Moore, Caroline M. ;
Pendse, Doug ;
Emberton, Mark .
NATURE CLINICAL PRACTICE UROLOGY, 2009, 6 (01) :18-30
[8]   Photophysics and photochemistry of photodynamic therapy: fundamental aspects [J].
Plaetzer, K. ;
Krammer, B. ;
Berlanda, J. ;
Berr, F. ;
Kiesslich, T. .
LASERS IN MEDICAL SCIENCE, 2009, 24 (02) :259-268
[9]   Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology [J].
Porter, Kimberly R. ;
McCarthy, Bridget J. ;
Freels, Sally ;
Kim, Yoonsang ;
Davis, Faith G. .
NEURO-ONCOLOGY, 2010, 12 (06) :520-527
[10]   Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma [J].
Quon, Harry ;
Grossman, Craig E. ;
Finlay, Jarod C. ;
Zhu, Timothy C. ;
Clemmens, Clarice S. ;
Malloy, Kelly M. ;
Busch, Theresa M. .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2011, 8 (02) :75-85